Related Experiment Video
Updated: Feb 16, 2026

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
Impact of Culture-Independent Diagnostic Testing on Recovery of Enteric Bacterial Infections
Aamer Imdad1, Fiona Retzer2, Linda S Thomas2
1D. Brent Polk Division of Pediatric Gastroenterology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Background:
Culture-independent diagnostic tests (CIDTs) are increasingly used to identify enteric pathogens. However, foodborne illness surveillance systems have relied upon culture confirmation to estimate disease burden and identify outbreaks through molecular subtyping. This study examined the impacts of CIDT and estimated costs for culture verification of Shigella, Salmonella, Shiga toxin-producing Escherichia coli (STEC), and Campylobacter at the Tennessee Department of Health Public Health Laboratory (PHL).
Methods:
This observational study included laboratory and epidemiological surveillance data collected between years 2013-2016 from patients with the reported enteric illness. We calculated pathogen recovery at PHL based on initial diagnostic test type reported at the clinical laboratory. Adjusted prevalence ratios (PRs) and 95% confidence intervals (CIs) were estimated with modified Poisson regression. Estimates of cost were calculated for pathogen recovery from CIDT-positive specimens compared to recovery from culture-derived isolates.
Results:
During the study period, PHL received 5553 specimens from clinical laboratories from patients with the enteric illness. Pathogen recovery was 57% (984/1713) from referred CIDT-positive stool specimens and 95% (3662/3840) from culture-derived isolates (PR, 0.61 [95% CI, .56-.66]). Pathogen recovery from CIDT-positive specimens varied based on pathogen type: Salmonella (72%), Shigella (64%), STEC (57%), and Campylobacter (26%). Compared to stool culture-derived isolates, the cost to recover pathogens from 100 CIDT-positive specimens was higher for Shigella (US $6192), Salmonella (US $18373), and STEC (US $27783).
Conclusions:
Pathogen recovery was low from CIDT-positive specimens for enteric bacteria. This has important implications for the current enteric disease surveillance system, outbreak detection, and costs for public health programs.
Insights
Culture-independent diagnostic tests (CIDTs) show lower pathogen recovery for enteric bacteria. This impacts foodborne illness surveillance, outbreak detection, and public health costs.
Area of Science:
- Foodborne illness surveillance
- Public health laboratory diagnostics
- Molecular subtyping
Background:
- Culture-independent diagnostic tests (CIDTs) are increasingly utilized for enteric pathogen identification.
- Traditional foodborne illness surveillance relies on culture confirmation for disease burden estimation and outbreak detection.
- This study evaluated the impact of CIDTs on pathogen recovery and culture verification costs for key enteric bacteria at a public health laboratory.
Purpose of the Study:
- To assess the pathogen recovery rates from specimens initially tested by CIDTs compared to culture-based methods.
- To estimate the associated costs of culture verification for Shigella, Salmonella, Shiga toxin-producing Escherichia coli (STEC), and Campylobacter.
- To understand the implications of CIDT use on public health surveillance systems.
Main Methods:
- An observational study utilizing laboratory and epidemiological data from 2013-2016.
- Calculation of pathogen recovery rates based on initial diagnostic test type (CIDT vs. culture).
- Modified Poisson regression used to estimate prevalence ratios; cost analysis compared CIDT-positive specimen recovery to culture-derived isolates.
Main Results:
- Pathogen recovery was significantly lower from CIDT-positive specimens (57%) compared to culture-derived isolates (95%).
- Recovery rates varied by pathogen: Salmonella (72%), Shigella (64%), STEC (57%), and Campylobacter (26%) from CIDT-positive specimens.
- Culture verification costs for 100 CIDT-positive specimens were higher for Shigella, Salmonella, and STEC compared to culture-derived isolates.
Conclusions:
- Low pathogen recovery from CIDT-positive specimens poses challenges for enteric disease surveillance.
- Current surveillance systems may underestimate disease burden and impact outbreak detection capabilities.
- The findings highlight significant cost implications for public health programs relying on culture verification.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests

